Thrombomodulin and endothelial dysfunction : a disease-modifier shared between malignant hypertension and atypical hemolytic uremic syndrome
- Author
- Marieke Demeulenaere (UGent) , Katrien Devreese (UGent) , Hilde Vanbelleghem, Julie De Zaeytijd (UGent) , Johan Vande Walle (UGent) , Wim Van Biesen (UGent) and Steven Van Laecke (UGent)
- Organization
- Keywords
- Endothelial, Malignant hypertension, Thrombomodulin, Thrombotic microangiopathy, HUMAN SOLUBLE THROMBOMODULIN, PROTEIN-C, THROMBOTIC MICROANGIOPATHY, THROMBOEMBOLIC DISEASE, CASE-COHORT, COMPLEMENT, MUTATIONS, PREECLAMPSIA, EXPRESSION, CELLS
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 960.22 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8569516
- MLA
- Demeulenaere, Marieke, et al. “Thrombomodulin and Endothelial Dysfunction : A Disease-Modifier Shared between Malignant Hypertension and Atypical Hemolytic Uremic Syndrome.” NEPHRON, vol. 140, no. 1, 2018, pp. 63–73, doi:10.1159/000490201.
- APA
- Demeulenaere, M., Devreese, K., Vanbelleghem, H., De Zaeytijd, J., Vande Walle, J., Van Biesen, W., & Van Laecke, S. (2018). Thrombomodulin and endothelial dysfunction : a disease-modifier shared between malignant hypertension and atypical hemolytic uremic syndrome. NEPHRON, 140(1), 63–73. https://doi.org/10.1159/000490201
- Chicago author-date
- Demeulenaere, Marieke, Katrien Devreese, Hilde Vanbelleghem, Julie De Zaeytijd, Johan Vande Walle, Wim Van Biesen, and Steven Van Laecke. 2018. “Thrombomodulin and Endothelial Dysfunction : A Disease-Modifier Shared between Malignant Hypertension and Atypical Hemolytic Uremic Syndrome.” NEPHRON 140 (1): 63–73. https://doi.org/10.1159/000490201.
- Chicago author-date (all authors)
- Demeulenaere, Marieke, Katrien Devreese, Hilde Vanbelleghem, Julie De Zaeytijd, Johan Vande Walle, Wim Van Biesen, and Steven Van Laecke. 2018. “Thrombomodulin and Endothelial Dysfunction : A Disease-Modifier Shared between Malignant Hypertension and Atypical Hemolytic Uremic Syndrome.” NEPHRON 140 (1): 63–73. doi:10.1159/000490201.
- Vancouver
- 1.Demeulenaere M, Devreese K, Vanbelleghem H, De Zaeytijd J, Vande Walle J, Van Biesen W, et al. Thrombomodulin and endothelial dysfunction : a disease-modifier shared between malignant hypertension and atypical hemolytic uremic syndrome. NEPHRON. 2018;140(1):63–73.
- IEEE
- [1]M. Demeulenaere et al., “Thrombomodulin and endothelial dysfunction : a disease-modifier shared between malignant hypertension and atypical hemolytic uremic syndrome,” NEPHRON, vol. 140, no. 1, pp. 63–73, 2018.
@article{8569516,
author = {{Demeulenaere, Marieke and Devreese, Katrien and Vanbelleghem, Hilde and De Zaeytijd, Julie and Vande Walle, Johan and Van Biesen, Wim and Van Laecke, Steven}},
issn = {{1660-8151}},
journal = {{NEPHRON}},
keywords = {{Endothelial,Malignant hypertension,Thrombomodulin,Thrombotic microangiopathy,HUMAN SOLUBLE THROMBOMODULIN,PROTEIN-C,THROMBOTIC MICROANGIOPATHY,THROMBOEMBOLIC DISEASE,CASE-COHORT,COMPLEMENT,MUTATIONS,PREECLAMPSIA,EXPRESSION,CELLS}},
language = {{eng}},
number = {{1}},
pages = {{63--73}},
title = {{Thrombomodulin and endothelial dysfunction : a disease-modifier shared between malignant hypertension and atypical hemolytic uremic syndrome}},
url = {{http://doi.org/10.1159/000490201}},
volume = {{140}},
year = {{2018}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: